Seyedahmad Seyedalinaghi - Tehran University of Medical Sciences, Tehran, Iran
Behnam Farhoudi - Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran
Hamid Harandi - Tehran University of Medical Sciences, Tehran, Iran
Mehrdad Mahalleh - Tehran, Iran
Omid Dadras - Department of Global Health and Socioepidemiology, Graduate School of Medicine, Kyoto University, Japan
Amin Alipour - Clinical Research Development Center, Amir-Almomenin Hospital, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran
Mohsen Alijani - Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran

Background: People with chronic illnesses, such as HIV infection, face many barriers in the way of adherence to the treatment. In this study, the researchers attempted to investigate the barriers and facilitators of adherence to antiretroviral therapy (ART) among patients with HIV. Methods: Focus group discussion (FGD) was conducted with the primary objectives of investigating the barriers to ART adherence. Nine participants with HIV infection were recruited through a purposive sampling method at Great Tehran Prison. Results: In terms of the influencing factors of non-adherence; the drug side effects, especially with Efavirenz, Methadone and opioids effects resolution due to interaction with antiretroviral drugs, forgetfulness, fear of hangover due to the missed or delayed Methadone use, inappropriate nutrition and lack of access to food supplements and poverty were noted by majority of participants. In addition, there were some less, but still important factors of non-adherence among the patients, which were mentioned in the manuscript of the article. Conclusion: The medications side effects, inappropriate methadone prescription, stigma, lack of family support, and unfavorable prison conditions were found to be the potential barriers of adherence to HIV medication, whilst a strong and realistic patient-physician relationship, psychosocial and family support, and knowledge regarding the level of CD۴ were amongst the possible facilitators for adherence to HIV medication in HIV-positive prisoners.

HIV, Prisons, Antiretroviral Therapy, Barriers